{"71892":{"#nid":"71892","#data":{"type":"news","title":"Tech Part of $31 M Translational Partnership","body":[{"value":"\u003Cp\u003EThe National Institutes of Health (NIH) has awarded more than $31 million over five years--one of the largest NIH grants in Georgia history--to a partnership of Atlanta academic, research and healthcare institutions focused on accelerating the translation of laboratory discoveries into healthcare innovations for patients. The partnership, named the Atlanta Clinical and Translational Science Institute (ACTSI), is led by Emory University, along with Morehouse School of Medicine, the Georgia Institute of Technology and Children\u0027s Healthcare of Atlanta. \n\u003C\/p\u003E\n\u003Cp\u003EThe primary partner institutions, along with major collaborators, will match the NIH award in additional financial commitments, space, personnel and other support. Georgia collaborators include the Georgia Research Alliance, Kaiser Permanente of Georgia, the Atlanta Veterans Affairs Medical Center, Georgia Bio (formerly the Georgia Biomedical Partnership), and Grady Memorial Hospital and Health System.\n\u003C\/p\u003E\n\u003Cp\u003EThe award is part of a new national clinical research consortium launched last year by the NIH and supported through Clinical and Translational Science Awards (CTSAs). Part of the NIH Roadmap for Medical Research, the consortium is designed to spur the transformation of clinical and translational research in the U.S. so that new treatments can be developed more efficiently and delivered more quickly to patients. \n\u003C\/p\u003E\n\u003Cp\u003EAs one of the early CTSA partners, the Atlanta CTSI is among the 12 recipients announced today who will join 12 announced in 2006 in a national network that will include 60 CTSAs when fully implemented in 2012. \n\u003C\/p\u003E\n\u003Cp\u003E\u0022The Atlanta Clinical and Translational Science Institute (ACTSI) will harness the tremendous and diverse scientific, technological and clinical strengths of these partner institutions,\u0022 says David S. Stephens, MD, executive associate dean for research in Emory University School of Medicine and principal investigator of the grant. \u0022The institute will function as a citywide magnet for clinical and translational research using discovery, training and community engagement to improve the healthcare of the Atlanta community.\u0022 \n\u003C\/p\u003E\n\u003Cp\u003E\u0022We have a unique opportunity to transform healthcare and eliminate health disparities by actively engaging the broader physician community, and sharing best practices,\u0022 says Elizabeth Ofili, MD, MPH, associate dean for clinical research, Morehouse School of Medicine and co-principal investigator. \u0022Such academic community partnerships are critical to the success of the Atlanta CTSI as we work to effectively translate scientific discoveries to improve the health of all Atlantans.\u0022\n\u003C\/p\u003E\n\u003Cp\u003EThe goals of the Atlanta CTSI mirror those of the national CTSA consortium - to create new and innovative programs that accelerate discovery, engage communities in clinical research and the development of new scientific knowledge; train and develop interdisciplinary investigative teams; and create new research tools and information technologies that improve human health.\n\u003C\/p\u003E\n\u003Cp\u003E\u0022This grant will bolster our research efforts and produce real solutions to improve the health of Georgia\u0027s citizens,\u0022 said Governor Sonny Perdue.  \u0022This announcement is another step along Georgia\u0027s path to becoming a leader in healthcare research.  Georgia is a center for innovation and collaboration, and we will continue to seek out opportunities to capitalize on Georgia\u0027s resources and talent.\u0022        \n\u003C\/p\u003E\n\u003Cp\u003E\u0022Emory, Morehouse School of Medicine, Georgia Tech and Children\u0027s all are distinguished national leaders in educational excellence, innovative multidisciplinary research and ethical and effective engagement with the community,\u0022 says Michael M.E. Johns, MD, CEO of Emory\u0027s Woodruff Health Sciences Center. \u0022The existing solid partnerships and the commitment of these Atlanta institutions to contribute their intellectual strengths, resources, technologies and clinical facilities to this joint effort provide an extraordinary opportunity to create a national model for translating research discoveries into the most advanced patient care.\u0022\n\u003C\/p\u003E\n\u003Cp\u003EEach institution will contribute strengths to the partnership that will help create unique and valuable synergies. Emory is a national leader in healthcare and biomedical research and Georgia Tech is a national leader in biomedical engineering and the application of innovative systems engineering to health care solutions. Morehouse School of Medicine is a leading historically black institution that brings ethnic diversity to the biomedical research community, addresses health disparities through successful community engagement and serves as a pipeline for training minority investigators.\n\u003C\/p\u003E\n\u003Cp\u003EBy partnering with Children\u0027s, the ACTSI also will create a new and innovative pediatric clinical and translational research center that builds on the established relationships of Emory, Morehouse School of Medicine and Children\u0027s and the shared healthcare they provide and adds new research relationships with Georgia Tech in bioinformatics.\n\u003C\/p\u003E\n\u003Cp\u003E\u0022This grant is a clear indication of the quality of the researchers at Emory, Morehouse School of Medicine, Georgia Tech and Children\u0027s Healthcare of Atlanta and the strong partnerships they have formed,\u0022 says Thomas J. Lawley, MD, dean of Emory University School of Medicine. \n\u003C\/p\u003E\n\u003Cp\u003ECollaborations with and strong support from the Georgia Research Alliance will create opportunities to foster and accelerate the development and application of new and emerging technologies, an effort also facilitated through Georgia Bio.  Collaborations with Kaiser Permanente of Georgia, the Centers for Disease Control and Prevention and the VA Medical Center will enable dynamic community, public health, informatics and population studies programs. \n\u003C\/p\u003E\n\u003Cp\u003EThe Atlanta CTSI will bring together laboratory scientists with clinical investigators, community clinicians, professional societies, and industry collaborators in a wide variety of dynamic programs and research projects. The institute will apply new research methods in genomics, imaging, nanotechnology, proteomics, metabolomics, glycomics and informatics to develop the most advanced and innovative therapies. It also will create and sustain partnerships with Atlanta\u0027s diverse communities to support community-based clinical research. \n\u003C\/p\u003E\n\u003Cp\u003EBy using new research approaches in drug discovery and design, predictive health, regenerative biology, health disparities, computational and life sciences, translational animal models, imaging, and vaccines, the institute\u0027s scientists will accelerate the transfer of new technology, therapeutics and applications into routine use and focus their collective scientific expertise on the most critical health problems facing our country today.\n\u003C\/p\u003E\n\u003Cp\u003EFor more information about the ACTSI, specific programs and primary investigators, see \u003Ca href=\u0022http:\/\/www.AtlantaCTSI.org\u0022 title=\u0022http:\/\/www.AtlantaCTSI.org\u0022\u003Ehttp:\/\/www.AtlantaCTSI.org\u003C\/a\u003E \n\u003C\/p\u003E\n\u003Cp\u003EFor information about the NIH national CTSA consortium, see \u003Ca href=\u0022http:\/\/www.ctsaweb.org\u0022 title=\u0022http:\/\/www.ctsaweb.org\u0022\u003Ehttp:\/\/www.ctsaweb.org\u003C\/a\u003E.\u003C\/p\u003E","summary":null,"format":"limited_html"}],"field_subtitle":"","field_summary":[{"value":"The National Institutes of Health (NIH) has awarded more than $31 million over five years -- one of the largest NIH grants in Georgia history -- to a partnership of Atlanta academic, research and healthcare institutions, including Georgia Tech, focused on accelerating the translation of laboratory discoveries into healthcare innovations for patients.","format":"limited_html"}],"field_summary_sentence":[{"value":"Partnership to move innovation from lab to clinic"}],"uid":"27281","created_gmt":"2007-09-18 00:00:00","changed_gmt":"2016-10-08 03:01:05","author":"Lisa Grovenstein","boilerplate_text":"","field_publication":"","field_article_url":"","dateline":{"date":"2007-09-18T00:00:00-04:00","iso_date":"2007-09-18T00:00:00-04:00","tz":"America\/New_York"},"extras":[],"hg_media":{"71893":{"id":"71893","type":"image","title":"Tech tower","body":null,"created":"1449177414","gmt_created":"2015-12-03 21:16:54","changed":"1475894647","gmt_changed":"2016-10-08 02:44:07"}},"media_ids":["71893"],"groups":[{"id":"1214","name":"News Room"}],"categories":[{"id":"129","name":"Institute and Campus"},{"id":"131","name":"Economic Development and Policy"},{"id":"145","name":"Engineering"},{"id":"146","name":"Life Sciences and Biology"},{"id":"135","name":"Research"}],"keywords":[{"id":"2270","name":"National Institutes of Health"},{"id":"2076","name":"NIH"},{"id":"2269","name":"translational research"}],"core_research_areas":[],"news_room_topics":[],"event_categories":[],"invited_audience":[],"affiliations":[],"classification":[],"areas_of_expertise":[],"news_and_recent_appearances":[],"phone":[],"contact":[{"value":"\u003Cstrong\u003ELisa Grovenstein\u003C\/strong\u003E\u003Cbr \/\u003ECommunications \u0026amp; Marketing\u003Cbr \/\u003E\u003Ca href=\u0022http:\/\/www.gatech.edu\/contact\/index.html?id=lgrovenste3\u0022\u003EContact Lisa Grovenstein\u003C\/a\u003E\u003Cbr \/\u003E\u003Cstrong\u003E404-894-8835\u003C\/strong\u003E","format":"limited_html"}],"email":["lisa.grovenstein@comm.gatech.edu"],"slides":[],"orientation":[],"userdata":""}}}